Malignant melanoma is very rare in the case of oculocutaneous albinism and approximately thirty cases have been reported in the literature. Sixty year old male patient with oculocutaneous albinism was operated four years ago at the right leg due to amelanotic malignant melanoma. The patient taken under follow-up postoperatively, presented with upper gastrointestinal system bleeding. Endoscopic biopsy was reported as malignant melanoma metastasis and than total gastrectomy was performed. There is yet no case with gastric metastasis presenting with oculocutaneous albinism and amelanotic malignant melanoma in the literature. The clinical aspects of this unique case are presented.
INTRODUCTION
Although malignant melanoma is a rare type of the skin cancers, it has the worst prognosis. Melanoma is responsible for 1% of all cancer related deaths. The most important factor in the development of melanoma is the UV light. Blond people with blue eyes are more sensitive to harmful effects of sun light and more prone to skin burns. However, while the most frequent skin cancer in amelanotic people are squamous and basal cell carcinoma respectively, malignant melanoma could be detected rarely. 1 Only 5% of malignant melanoma patients are amelanotic. 2 Oculocutaneous albinism is an autosomal resessive disorder characterized by general loss of pigmentation, nistagmus, photofobia and decrease in sight.
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CASE REPORT
Sixty year old male patient with oculocutaneous albinism admitted to our hospital with a mass at the right foot in 2004. The excisional biopsy result of the mass was reported to be amelanotic malignant melanoma (Clark Level III). The patient without metastasis was taken for follow-up without treatment. Three years later he admitted to our clinics with complaints such as fatigue, abdominal pain, weight loss and hematemesis. At the physical examination general loss of pigmentation, blue eyes, strabismus, nistagmus, decrease in sight, paleness in conjunctiva and melena in rectal examination, were determined. A mass was determined at the gastric corpus in upper gastrointestinal system endoscopy and biopsy was taken. Pathology result was reported as in accordance with malignant melanoma metastasis. Total gastrectomy operation was performed because of recurrent persistent gastrointestinal bleeding. During the operation three seperate metastatic foci were determined at the gastric corpus, one of which exceeded the wall. Malignant melanoma metastasis was noted at six perigastric lymph nodes. In pathological examination, spindle cells was detected with hematoxylin -eosin (Figure 1) , and S-100 ( Figure 2 ) and HMB-45 (Figure 3) positivity were also detected with immunohistochemical staining. Postoperative chemotherapy with temazolamide (200 mg/m 2 / 1-5 days once 28 days) was initiated for the patient. The patient died because of progression of dissease after two cycles chemotherapy.
DISCUSSION
In malignant melanoma while the number of melanocytes are normal, there is a defect in the production of melanin. They generally metastase to skin, subcutaneous tissue and lymp nodes. The most frequent sites of visseral metastasis are lung, brain, liver, gastrointestinal system and bone. 4% incidence of gastrointestinal system metastasis when they are alive, this increases to over 60% in autopsy series. 4 In studies on gastrointestinal system, metastasis was observed to small intestine, colon and stomach at percentages of 35-70%, 14.5-2.2% and 7-20% respectively. 5, 6 Gastrointestinal system melanoma could be detected primarily or metastatically. One of the hypothesis for the development of gastric melanoma is the development from ectopic melanocytes at the gastric wall as a result of the migration of melanocytes to gastrointestinal system during embryogenesis. 7 However; gastric melanoma is a metastasis of cutaneous melanoma according to some authors. Primary skin melanoma is either missed during examination or the primary lesion spontaneously regresses. 8 The determination of gastrointestinal system metastasis in over 60% of cutaneous melanoma cases at autopsy series, supports this hypothesis. Thus, we evaluated gastric involvement as metastasis due to the presence of cutaneous melanoma history and determination of multiple gastric metastasis in our patient.
Symptoms developed due to gastric metastasis of melanomas include abdominal pain, loss of weight, anemia and bleeding same as other gastric tumors. 7 The presentation of our patient was in accordance with these symptoms.
Although there is not a full consensus for the treatment of metastatic melanoma, treatment alternatives include surgery, radiotherapy, chemotherapy, immunotherapy and combination of these treatments. It was shown in various studies that curative or palliative surgery increased survival in the involvement of gastrointestinal system. 9 At the metastatic level; dacarbazine, temazolamide, IL-2, paclitaxel or combinations are recent treatment alternatives. We chose temazolamide treatment in our patient as it could be used orally, had a tolerable side effect profile and similar treatment response.
As a conclusion; the prognosis of malignant melanoma patients is stil not at the desired level despite the improvements at surgical and medical treatments together with early diagnostic methods.
There is yet no case with gastric metastasis presenting with oculocutaneous albinism and amelanotic malignant melanoma in the literature. The clinical aspects of this unique case are presented. 
